Vera Therapeutics Inc (VERA)
43.44
-0.06
(-0.14%)
USD |
NASDAQ |
May 03, 16:00
43.45
+0.01
(+0.02%)
After-Hours: 20:00
Vera Therapeutics Total Assets (Quarterly): 175.55M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 175.55M |
| September 30, 2023 | 175.62M |
| June 30, 2023 | 195.18M |
| March 31, 2023 | 209.60M |
| December 31, 2022 | 131.44M |
| September 30, 2022 | 131.37M |
| June 30, 2022 | 148.78M |
| Date | Value |
|---|---|
| March 31, 2022 | 164.97M |
| December 31, 2021 | 83.75M |
| September 30, 2021 | 91.17M |
| June 30, 2021 | 97.65M |
| March 31, 2021 | 51.82M |
| December 31, 2020 | 54.55M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
51.82M
Minimum
Mar 2021
209.60M
Maximum
Mar 2023
131.65M
Average
131.44M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 22.73B |
| Alpine Immune Sciences Inc | 379.85M |
| Fate Therapeutics Inc | 506.22M |
| Mersana Therapeutics Inc | 226.06M |
| Equillium Inc | 50.53M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 73.86M |
| Shareholders Equity (Quarterly) | 101.68M |